Contribution of a Video Support to Inform the Patient Before a Complementary Examination in Infectious Diseases (AVIEMI)

March 24, 2026 updated by: Assistance Publique - Hôpitaux de Paris

Non Interventional Study Evaluating the Contribution of a Video to Patient Information Before a Complementary Examination in Infectious Diseases

The purpose of this study is that a video tool coupled with standardized information can increase the patient's understanding of the information and thus optimize their medical care

Study Overview

Detailed Description

Patients admitted to the Infectious and Tropical Diseases Department (MIT) undergo a large number of complementary examinations. In view of their specificity, justified by the often lengthy diagnostic process, as well as by the complexity and diversity of the pathologies, the site of infection and the patient's background (adolescents and adults, migrant patients, immunocompromised patients, Human Immunodeficiency Virus, primary immunodeficiencies, organ transplants, patients with haemopathies, marrow transplants, among others). As a matter of practice, the doctor informs the patient of the prescribed examinations, explaining their purpose and procedure, and outlining any benefits and risks.

The intention is to introduce a tool that complements the information usually provided, and that can be of high quality to improve the patient's perception of understanding. To this end, investigators hypothesize that a tool in video format, built in collaboration with the experience of various technical platforms, could make the experience of understanding information more complete and more accessible to all patients.

Study Type

Observational

Enrollment (Actual)

97

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75015
        • Hôpital Necker Enfants Malades

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Hospitalized patients in the Department of Infectious and Tropical Diseases at Hôpital Necker- Enfants maladies.

Caregivers working in the Infectious and Tropical Diseases Department at Necker Hospital

Description

Inclusion Criteria:

  • Patient aged ≥ 18 years
  • French speaking language
  • Hospitalized in the Department of Infectious and Tropical Diseases at Hôpital Necker- Enfants malades
  • Prescription, for the first time in its medical history, of one of the following complementary examinations:

    • Bronchial FibroscopyIRM
    • PICC line insertion
    • PET Scanner
  • No expressed oral opposition

Exclusion Criteria:

  • Patients with dementia or cognitive impairment
  • Non-French-speaking patient

Caregivers' inclusion Criteria:

  • Caregiver belonging at nurse or doctor's category
  • Caregiver working in the Infectious and Tropical Diseases Department at Necker Hospital
  • No expressed oral opposition
  • Caregivers who are not in contact with patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1 : Patients with oral and written information

Group made up of patients hospitalized at that time in the infectious diseases department who met the eligibility criteria set out in the protocol.

This group of patients will receive the legal oral and written information concerning the additional examination prescribed, as usually delivered by their doctor.

Legal oral and written information given by physicians concerning additional examinations
Group 2 : Patients with oral and written information + video information

Group made up of patients hospitalized at that time in the infectious diseases department who met the eligibility criteria set out in the protocol.

This group of patients will receive the legal oral and written information concerning the additional examination prescribed, as usually delivered by their physician, and in addition the video tool will be applied to them.

Legal oral and written information given by physicians concerning additional examinations
Explanatory video applied after physician's formal information
Group 3 : Caregivers

Nurses and physicians working in the infectious and tropical diseases department.

This group of caregivers will assess the impact of the intervention on their practice.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score of perceived understanding of information before additional examination
Time Frame: up to 7 days
Measure the patient's perception of comprehension prior to the examination, using a self-assessment Numerical Scale (NRS) defined from zero (no comprehension) to ten (perfect comprehension). The assessment will be collected by a caregiver who is not in charge of the patient, within a maximum of 24 hours after the carried out examination.
up to 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score of perceived understanding of information after additional examination
Time Frame: up to 7 days
Measure the patient's perception of comprehension after the examination, using a self-assessment Numerical Scale (NRS) defined from zero (no comprehension) to ten (perfect comprehension).
up to 7 days
Failure rate of examinations
Time Frame: up to 7 days
A failure is defined as an examination not performed and/or an examination that cannot be interpreted. The failure is recorded upon return from the examination via the report provided by the technical platform and certified by the physician
up to 7 days
Missing elements
Time Frame: up to 7 days
Collection of elements identified as missing by the patient during the examination. A questionnaire will completed by the patient at his return, in a maximum of 24 hours
up to 7 days
Impact on caregivers' knowledge
Time Frame: 1 day
using a self-questionnaire
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Fanny LANTERNIER, MD, PhD, Assistance Publique - Hôpitaux de Paris
  • Principal Investigator: Elisabete GOMES-PIRES, Nurse, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2023

Primary Completion (Actual)

February 11, 2025

Study Completion (Actual)

February 14, 2025

Study Registration Dates

First Submitted

December 5, 2023

First Submitted That Met QC Criteria

December 5, 2023

First Posted (Actual)

December 13, 2023

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infectious Disease

Clinical Trials on Oral and written information

Subscribe